| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Absence of mutations in the activation loop and juxtamembrane domains of VEGFR-1 and VEGFR-2 gene in chronic myelomonocytic leukemia (CMML)
|
Such, Esperanza
|
|
2012
|
36 |
Supplement 1 |
p. e50-e51
nvt p.
|
artikel
|
| 2 |
A combination of methotrexate and irradiation promotes cell death in NK/T-cell lymphoma cells via down-regulation of NF-κB signaling
|
Kim, Areumnuri
|
|
2012
|
36 |
Supplement 1 |
p. 350-357
8 p.
|
artikel
|
| 3 |
Acute myeloid leukemia targeting by myxoma virus in vivo depends on cell binding but not permissiveness to infection in vitro
|
Madlambayan, Gerard J.
|
|
2012
|
36 |
Supplement 1 |
p. 619-624
6 p.
|
artikel
|
| 4 |
Adverse impact of IDH1 and IDH2 mutations in primary AML: Experience of the Spanish CETLAM group
|
Nomdedéu, J.
|
|
2012
|
36 |
Supplement 1 |
p. 990-997
8 p.
|
artikel
|
| 5 |
Allogeneic stem cell transplantation for myeloproliferative neoplasm in blast phase
|
Cherington, Chad
|
|
2012
|
36 |
Supplement 1 |
p. 1147-1151
5 p.
|
artikel
|
| 6 |
Analysis of T-cell receptor-γ gene rearrangements using heteroduplex analysis by high-resolution microcapillary electrophoresis
|
Beaufils, Nathalie
|
|
2012
|
36 |
Supplement 1 |
p. 1119-1123
5 p.
|
artikel
|
| 7 |
Angiogenic factors in chronic lymphocytic leukemia
|
Xia, Yi
|
|
2012
|
36 |
Supplement 1 |
p. 1211-1217
7 p.
|
artikel
|
| 8 |
Cardamonin exerts potent activity against multiple myeloma through blockade of NF-κB pathway in vitro
|
Qin, You
|
|
2012
|
36 |
Supplement 1 |
p. 514-520
7 p.
|
artikel
|
| 9 |
CD44 activation enhances acute monoblastic leukemia cell survival via Mcl-1 upregulation
|
Sansonetti, Arnaud
|
|
2012
|
36 |
Supplement 1 |
p. 358-362
5 p.
|
artikel
|
| 10 |
Clinical importance of SF3B1 mutations in Chinese with myelodysplastic syndromes with ring sideroblasts
|
Cui, Rui
|
|
2012
|
36 |
Supplement 1 |
p. 1428-1433
6 p.
|
artikel
|
| 11 |
Dasatinib inhibits leukaemic cell survival by decreasing PRH/Hhex phosphorylation resulting in increased repression of VEGF signalling genes
|
Noy, Peter
|
|
2012
|
36 |
Supplement 1 |
p. 1434-1437
4 p.
|
artikel
|
| 12 |
Disease control in patients with relapsed and/or refractory multiple myeloma: what is the optimal duration of therapy?
|
Ludwig, Heinz
|
|
2012
|
36 |
Supplement 1 |
p. S27-S34
8 p.
|
artikel
|
| 13 |
Downregulation of IRS2 in myelodysplastic syndrome: A possible role in impaired hematopoietic cell differentiation
|
Machado-Neto, João Agostinho
|
|
2012
|
36 |
Supplement 1 |
p. 931-935
5 p.
|
artikel
|
| 14 |
Elevated HIF-1α expression of acute myelogenous leukemia stem cells in the endosteal hypoxic zone may be a cause of minimal residual disease in bone marrow after chemotherapy
|
Matsunaga, T.
|
|
2012
|
36 |
Supplement 1 |
p. e122-e124
nvt p.
|
artikel
|
| 15 |
Endoplasmic reticulum stress contributes to arsenic trioxide-induced apoptosis in drug-sensitive and -resistant leukemia cells
|
Chen, Jing
|
|
2012
|
36 |
Supplement 1 |
p. 1526-1535
10 p.
|
artikel
|
| 16 |
Evidence for functional trace amine associated receptor-1 in normal and malignant B cells
|
Wasik, Agata M.
|
|
2012
|
36 |
Supplement 1 |
p. 245-249
5 p.
|
artikel
|
| 17 |
Gadd45a transcriptional induction elicited by the Aurora kinase inhibitor MK-0457 in Bcr-Abl-expressing cells is driven by Oct-1 transcription factor
|
Mancini, Manuela
|
|
2012
|
36 |
Supplement 1 |
p. 1028-1034
7 p.
|
artikel
|
| 18 |
Gli inhibitor GANT61 causes apoptosis in myeloid leukemia cells and acts in synergy with rapamycin
|
Pan, Deng
|
|
2012
|
36 |
Supplement 1 |
p. 742-748
7 p.
|
artikel
|
| 19 |
HDAC6 as a target for antileukemic drugs in acute myeloid leukemia
|
Hackanson, Björn
|
|
2012
|
36 |
Supplement 1 |
p. 1055-1062
8 p.
|
artikel
|
| 20 |
High expression of hematopoietic cell specific Lyn substrate-1 (HS1) predicts poor survival of B-cell chronic lymphocytic leukemia patients
|
Butrym, Aleksandra
|
|
2012
|
36 |
Supplement 1 |
p. 876-880
5 p.
|
artikel
|
| 21 |
Hypereosinophilic syndrome in children
|
van Grotel, M.
|
|
2012
|
36 |
Supplement 1 |
p. 1249-1254
6 p.
|
artikel
|
| 22 |
Imatinib mesylate discontinuation in patients with chronic myeloid leukemia who have received front-line imatinib mesylate therapy and achieved complete molecular response
|
Yhim, Ho-Young
|
|
2012
|
36 |
Supplement 1 |
p. 689-693
5 p.
|
artikel
|
| 23 |
Importance of local hypoxia on endothelial phenotype for an in vitro approach to bone marrow angiogenesis
|
Gouel, Flore
|
|
2012
|
36 |
Supplement 1 |
p. 1200-1203
4 p.
|
artikel
|
| 24 |
Induction of differentiation and apoptosis in leukaemic cell lines by the novel benzamide family histone deacetylase 2 and 3 inhibitor MI-192
|
Boissinot, Marjorie
|
|
2012
|
36 |
Supplement 1 |
p. 1304-1310
7 p.
|
artikel
|
| 25 |
Influence of JAK2 46/1 haplotype in the natural evolution of JAK2V617F allele burden in patients with myeloproliferative neoplasms
|
Alvarez-Larrán, Alberto
|
|
2012
|
36 |
Supplement 1 |
p. 324-326
3 p.
|
artikel
|
| 26 |
Inhibition of damage-regulated autophagy modulator-1 (DRAM-1) impairs neutrophil differentiation of NB4 APL cells
|
Humbert, Magali
|
|
2012
|
36 |
Supplement 1 |
p. 1552-1556
5 p.
|
artikel
|
| 27 |
In the absence of clinically significant graft vs. host disease, myeloablative conditioning may allow an effective graft vs. leukaemia effect
|
Novitzky, N.
|
|
2012
|
36 |
Supplement 1 |
p. 104-109
6 p.
|
artikel
|
| 28 |
MiR-15a, miR-16-1 and miR-17-92 cluster expression are linked to poor prognosis in multiple myeloma
|
Gao, Xiao
|
|
2012
|
36 |
Supplement 1 |
p. 1505-1509
5 p.
|
artikel
|
| 29 |
Morphologic analysis in myelodysplastic syndromes with del(5q) treated with lenalidomide. A Japanese multiinstitutional study
|
Matsuda, Akira
|
|
2012
|
36 |
Supplement 1 |
p. 575-580
6 p.
|
artikel
|
| 30 |
Notch-mediated repression of miR-223 contributes to IGF1R regulation in T-ALL
|
Gusscott, Samuel
|
|
2012
|
36 |
Supplement 1 |
p. 905-911
7 p.
|
artikel
|
| 31 |
Novel agents and the paradigm of continuous treatment in multiple myeloma
|
Palumbo, Antonio
|
|
2012
|
36 |
Supplement 1 |
p. S1-S2
2 p.
|
artikel
|
| 32 |
Pentamidine sensitizes chronic myelogenous leukemia K562 cells to TRAIL-induced apoptosis
|
Qiu, Geng
|
|
2012
|
36 |
Supplement 1 |
p. 1417-1421
5 p.
|
artikel
|
| 33 |
Pharmacokinetics of CPX-351; a nano-scale liposomal fixed molar ratio formulation of cytarabine:daunorubicin, in patients with advanced leukemia
|
Feldman, E.J.
|
|
2012
|
36 |
Supplement 1 |
p. 1283-1289
7 p.
|
artikel
|
| 34 |
Phase II study on combination therapy with CHOP-Zenapax for HTLV-I associated adult T-cell leukaemia/lymphoma (ATLL)
|
Ceesay, M. Mansour
|
|
2012
|
36 |
Supplement 1 |
p. 857-861
5 p.
|
artikel
|
| 35 |
Post-transcriptional modulation of C/EBPα prompts monocytic differentiation and apoptosis in acute myelomonocytic leukaemia cells
|
Yoshida, Hideki
|
|
2012
|
36 |
Supplement 1 |
p. 735-741
7 p.
|
artikel
|
| 36 |
Proteomic analysis identifies differentially expressed proteins in AML1/ETO acute myeloid leukemia cells treated with DNMT inhibitors azacitidine and decitabine
|
Buchi, Francesca
|
|
2012
|
36 |
Supplement 1 |
p. 607-618
12 p.
|
artikel
|
| 37 |
Reduced intensity allogeneic hematopoietic stem cell transplantation for MDS using tacrolimus/sirolimus-based GVHD prophylaxis
|
Nakamura, Ryotaro
|
|
2012
|
36 |
Supplement 1 |
p. 1152-1156
5 p.
|
artikel
|
| 38 |
Retraction notice to “Curcumin suppresses constitutive activation of AP-1 by downregulation of JunD protein in HTLV-1-infected T-cell lines” [Leuk. Res. 30 (2006) 313–321]
|
Tomita, Mariko
|
|
2012
|
36 |
Supplement 1 |
p. 661-
1 p.
|
artikel
|
| 39 |
Rituximab in combination with high-dose dexamethasone for the treatment of relapsed/refractory chronic lymphocytic leukemia
|
Smolej, Lukáš
|
|
2012
|
36 |
Supplement 1 |
p. 1278-1282
5 p.
|
artikel
|
| 40 |
Role of Neuropilin-1 and its expression in Egyptian Acute Myeloid and Acute Lymphoid Leukemia patients
|
Younan, Sarah
|
|
2012
|
36 |
Supplement 1 |
p. 169-173
5 p.
|
artikel
|
| 41 |
SDF-1/CXCR4 axis in myelodysplastic syndromes: Correlation with angiogenesis and apoptosis
|
Zhang, Yizhuo
|
|
2012
|
36 |
Supplement 1 |
p. 281-286
6 p.
|
artikel
|
| 42 |
The degree of neutropenia has a prognostic impact in low risk myelodysplastic syndrome
|
Cordoba, I.
|
|
2012
|
36 |
Supplement 1 |
p. 287-292
6 p.
|
artikel
|
| 43 |
The granulocyte-associated transcription factor Krüppel-like factor 5 is silenced by hypermethylation in acute myeloid leukemia
|
Diakiw, Sonya M.
|
|
2012
|
36 |
Supplement 1 |
p. 110-116
7 p.
|
artikel
|
| 44 |
Therapy with the histone deacetylase inhibitor pracinostat for patients with myelofibrosis
|
Quintás-Cardama, Alfonso
|
|
2012
|
36 |
Supplement 1 |
p. 1124-1127
4 p.
|
artikel
|
| 45 |
The Smac mimetic RMT5265.2HCL induces apoptosis in EBV and HTLV-I associated lymphoma cells by inhibiting XIAP and promoting the mitochondrial release of cytochrome C and Smac
|
Ramachandiran, Sampath
|
|
2012
|
36 |
Supplement 1 |
p. 784-790
7 p.
|
artikel
|
| 46 |
The study of resistant mechanisms and reversal in an imatinib resistant Ph+ acute lymphoblastic leukemia cell line
|
Xing, Hongyun
|
|
2012
|
36 |
Supplement 1 |
p. 509-513
5 p.
|
artikel
|
| 47 |
Thrombocytopenia at diagnosis as an important negative prognostic marker in isolated 5q− MDS (IPSS low and intermediate-1)
|
Jonasova, Anna
|
|
2012
|
36 |
Supplement 1 |
p. e222-e224
nvt p.
|
artikel
|
| 48 |
Thrombomodulin-induced differentiation of acute myelomonocytic leukemia cells via JNK signaling
|
Yang, Jing
|
|
2012
|
36 |
Supplement 1 |
p. 625-633
9 p.
|
artikel
|
| 49 |
Use of pegylated interferon in hypereosinophilic syndrome
|
Butterfield, Joseph H.
|
|
2012
|
36 |
Supplement 1 |
p. 192-197
6 p.
|
artikel
|
| 50 |
Will a peripheral blood (PB) sample yield the same diagnostic and prognostic cytogenetic data as the concomitant bone marrow (BM) in myelodysplasia?
|
Cherry, Athena M.
|
|
2012
|
36 |
Supplement 1 |
p. 832-840
9 p.
|
artikel
|
Tijdschrift beschrijving